Groupe d'Etude en Oncologie du Quebec

Titre	Spatially Fractionated Radiation (SFR) Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors
Protocole ID	GRID
ClinicalTrials.gov ID	NCT02333110
Type(s) de cancer	Tumeurs solides
Phase
Stade	Maladie avancée ou métastatique
Type étude	Support
Institution	CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS 3755 rue de la Côte Ste. Catherine, Montréal, QC, H3T 1E2
Ville	Montréal
Investigateur(trice) principal(e)	Dre Té Vuong
Coordonnateur(trice)	Harielle Lamarre 514-340-8222 poste 26199
Statut	Actif en recrutement
Critètes d'éligibilité	Patient with histologically or cytologically confirmed malignancy. All malignant histologies/cytologies are eligible. Patient with bulky tumor (larger than 8cm), or with a tumor known to be resistant to radiation (eg. Melanoma, hypernephroma, sarcoma), or with a tumor previously irradiated with a palliative intent requiring more than 1 fraction of radiation Patient planned to undergo palliative radiation therapy treatments to one of the following 5 sites: extremities, neck, chest, abdomen and pelvis WHO performance status of 0-2 Aged 18 years or older Ability to sign and understand an informed consent form
Critètes d'exclusion	Potentially curable patient Previous palliative radiation with hypofractionation Tumor located near the spinal cord or in the brain Pregnant or nursing woman

Groupe d'étude en oncologie du Québec